Giancarlo Isacchi MD, Nicola Giuliano, Lucia Granati MD, Giuseppe Polino MD, Pellegrina Pugliese MD, Vittorio Rosato PhD, Francesco Malagnino MD
{"title":"新细胞的制备和输血:地中海贫血儿童的经验","authors":"Giancarlo Isacchi MD, Nicola Giuliano, Lucia Granati MD, Giuseppe Polino MD, Pellegrina Pugliese MD, Vittorio Rosato PhD, Francesco Malagnino MD","doi":"10.1016/0278-6222(88)90024-1","DOIUrl":null,"url":null,"abstract":"<div><p>The use of neocytes has been developed as a system to reduce transfusion requirement and consequent iron overload. Neocyte concentrates prepared with the IBM 2991 Blood Processor have been transfused in 14 patients with Cooley's anemia (two groups of nine and five patients respectively). Analysis of the clinical advantages of neocytes has demonstrated that (1) the reduction of the blood requirement was about 10%; (2) the cost of a neocyte unit is considerable compared with the standard blood unit; and (3) the risk of alloimmunization and blood-dependent infectious disease is increased, in proportion to the large numbers of blood donors.</p></div>","PeriodicalId":101030,"journal":{"name":"Plasma Therapy and Transfusion Technology","volume":"9 1","pages":"Pages 7-10"},"PeriodicalIF":0.0000,"publicationDate":"1988-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0278-6222(88)90024-1","citationCount":"1","resultStr":"{\"title\":\"Preparation and transfusion of neocytes: Experience in children with thalassemia\",\"authors\":\"Giancarlo Isacchi MD, Nicola Giuliano, Lucia Granati MD, Giuseppe Polino MD, Pellegrina Pugliese MD, Vittorio Rosato PhD, Francesco Malagnino MD\",\"doi\":\"10.1016/0278-6222(88)90024-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The use of neocytes has been developed as a system to reduce transfusion requirement and consequent iron overload. Neocyte concentrates prepared with the IBM 2991 Blood Processor have been transfused in 14 patients with Cooley's anemia (two groups of nine and five patients respectively). Analysis of the clinical advantages of neocytes has demonstrated that (1) the reduction of the blood requirement was about 10%; (2) the cost of a neocyte unit is considerable compared with the standard blood unit; and (3) the risk of alloimmunization and blood-dependent infectious disease is increased, in proportion to the large numbers of blood donors.</p></div>\",\"PeriodicalId\":101030,\"journal\":{\"name\":\"Plasma Therapy and Transfusion Technology\",\"volume\":\"9 1\",\"pages\":\"Pages 7-10\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1988-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/0278-6222(88)90024-1\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Plasma Therapy and Transfusion Technology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/0278622288900241\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Plasma Therapy and Transfusion Technology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/0278622288900241","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Preparation and transfusion of neocytes: Experience in children with thalassemia
The use of neocytes has been developed as a system to reduce transfusion requirement and consequent iron overload. Neocyte concentrates prepared with the IBM 2991 Blood Processor have been transfused in 14 patients with Cooley's anemia (two groups of nine and five patients respectively). Analysis of the clinical advantages of neocytes has demonstrated that (1) the reduction of the blood requirement was about 10%; (2) the cost of a neocyte unit is considerable compared with the standard blood unit; and (3) the risk of alloimmunization and blood-dependent infectious disease is increased, in proportion to the large numbers of blood donors.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
